Favorable therapeutic index of an orally-active small-molecule antagonist of the platelet protease-activated receptor-4, BMS-986141, compared with the P2Y12 antagonist ticagrelor in cynomolgus monkeys
1 September 2020 (08:30 - 08:30)
Organised by:
Abstract
Slides
About the speaker
Bristol Myers Squibb, Princeton (United States of America)
6 More presentations in this session
Doctor P. Sansilvestri-Morel (Suresnes, FR)
Doctor P. Sulzgruber (Krems an der Donau, AT)
Access the full session
The Event
ESC Congress 2020
1 September 2020
08:30 CET
